News 2023/11/06 Abionic and Lascco partner with Fapon for sepsis diagnosis in China Biopôle companies Abionic and Lascco team up with Fapon to harness a groundbreaking biomarker for sepsis detection, enhancing early diagnosis cap...
News 2024/03/26 Top Stories from Western Switzerland (March 2024) From innovative approaches in cardiac care and sustainable plastics to enhancing spinal cord injury therapies and advancing virtual power plants,...
News 2023/11/06 Vaud-based LAGOSTA and global giant Merck collaborate on chitosan distribution Biotech company LAGOSTA has announced a collaboration with Merck. The partnership aims to facilitate the distribution of LAGOSTA's superior chito...
最新 2023/11/09 瑞士Abionic和Lascco公司与菲鹏生物合作,助力中国医生诊断脓毒症 位于洛桑Biopôle生命科学园区的Abionic和Lascco公司,与中国菲鹏生物合作,利用突破性的生物标志物进行脓毒症检测,增强早期诊断能力。
News 2023/10/18 Siegfried and Lonza secure top positions in global pharmaceutical outsourcing rankings Valais-based pharmaceutical companies Lonza and Siegfried have been recognized among the leading players in the global outsourcing landscape, wit...
Analisi 2021/03/22 Marketing digitale B2B in China Il panorama digitale in Cina è unico e in rapida evoluzione, molto diverso da quello europeo. Per scoprire come se la cavano le aziende svizzere ...
Analyse 2021/03/22 Digitales B2B-Marketing in China Die digitale Landschaft in China ist einzigartig und in rasanter Entwicklung, ganz anders als in Europa. Um herauszufinden, wo Schweizer Unterneh...
News 2023/06/07 Genedata expanding its user network The Japanese biopharmaceutical firm Ajinomoto is to use the Genedata solution to accelerate its drug development processes at its site in South K...
Analysis 2021/03/22 B2B Digital Marketing in China The digital landscape in China is unique and fast-evolving, way different than in Europe. In order to find out how the Swiss companies in China a...
Aktuell 2023/06/07 Genedata weitet Netz seiner Nutzer aus Das japanische Biopharma-Unternehmen Ajinomoto setzt die Lösung von Genedata zur Beschleunigung seiner Medikamentenentwicklung künftig auch an se...
News 2023/02/23 Xeltis raises 32 million euros The medtech firm Xeltis has raised a total of 32 million euros after successfully closing a financing round. Xeltis has also concluded a licensin...
Aktuell 2023/02/23 Xeltis sammelt 32 Millionen Euro ein Das Medtech-Unternehmen Xeltis hat in einer Finanzierungsrunde 32 Millionen Euro eingenommen. Ausserdem hat Xeltis mit Grand Pharma eine Lizenzve...
Exporteure im Fokus 2022/06/27 Unternehmen profitieren vom Freihandelsabkommen Schweiz-China Als einziges kontinentaleuropäisches Land verfügt die Schweiz seit dem 1. Juli 2014 über ein umfassendes Freihandelsabkommen mit China. Im fünfte...
News 2022/11/23 Geneva biopharma ObsEva sells its Ebopiprant license for up to USD 113 million Women's and reproductive health specialist ObsEva has announced the sale of its license for ebopiprant to California-based biotech company Xoma f...
News 2023/05/26 UCB: "It's difficult to beat Swiss quality - even the Chinese admit as much." UCB UCB is a global biopharmaceutical company based in Belgium. Since 1996, it has invested more than 600 million Swiss francs in a state-of-the-art ...
Focus on exporters 2018/09/27 Companies benefit from free trade agreement between Switzerland and China Since 1 July 2014, Switzerland has been the only continental European country to have signed a comprehensive free trade agreement (FTA) with Chin...
Analyse 2021/03/22 Marketing digital B2B en Chine En constante évolution, le paysage du numérique chinois est unique en son genre et radicalement différent de son équivalent européen. Afin de sav...